The Supreme Court of India has held that stem cell therapy for the treatment of Autism Spectrum Disorder (ASD) cannot be offered by medical practitioners as a routine clinical service. In a significant judgment delivered on January 30, 2026, the Bench comprising Justice J.B. Pardiwala and Justice R. Mahadevan ruled that such treatment must be
Stem Cell Therapy for Autism Spectrum Disorder Cannot Be Offered as Routine Clinical Service; Must Be Restricted to Clinical Trials: Supreme Court
